Clinical trials: Compulsion

Obsessive-Compulsive Behavior

rTMS Device for Improvement of Obsessive and Compulsive Behaviors

• Not yet recruiting
• Age: 22 years and older
• Medical device

The goal of this investigational study is to evaluate if the treatment using EXOMIND(BTL-699-2) device is able to improve severity of obsessive and compulsive symptoms in adults (aged 22 and older).

Trial name

NCT07679750

Testing

EXOMIND (BTL-699-2) Active treatment

Where

3 sites in United States

Volunteers

60 people, healthy volunteers welcome

Sponsor

BTL Industries Ltd.